2.51 (3.21%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Strong
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Kymera Therapeutics, Inc.
Telephone
1.857.285.5300
Address
4th floor, 500 North Beacon Street, Watertown, MA 02472
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 28.06 - 103
Trade Value (12mth)
US$13,106,718.00
1 week
-4.95%
1 month
-11.28%
YTD
7.39%
1 year
159.34%
All time high
103.00
EPS 3 yr Growth
28.40%
EBITDA Margin
-860.00%
Operating Cashflow
-$233m
Free Cash Flow Return
-18.20%
ROIC
-24.30%
Interest Coverage
-911.40
Quick Ratio
10.50
Shares Outstanding (Fully Diluted)
98m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 30 April 26 | |
| 30 April 26 | |
| 28 March 26 | |
| 27 February 26 | |
| 27 February 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2.52 | -2.98 | -3.68 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2.52 | -2.98 | -3.68 | | | | ||
Growth | % | | | | | 12.3 | -18.5 | -23.5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
